Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03547206 |
| Consolidated Lead Sponsor | Regenera Pharma |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 165 participants (ACTUAL) |
| Registered Start Date | 2018-07-10 |
| WhyStopped Classification | Unspecified |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Stanford Health Care and Stanford Cancer Institute | Stanford, CA | Open Hospital Dossier -> |
| UCLA Health and Jonsson Comprehensive Cancer Center | Los Angeles, CA | Open Hospital Dossier -> |
| Emory Winship Cancer Institute | Atlanta, GA | Open Hospital Dossier -> |
| Washington University and Siteman Cancer Center | Saint Louis, MO | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.